Mebendazole as Adjuvant Treatment for Colon Cancer

Last updated: April 22, 2019
Sponsor: Sherief Abd-Elsalam
Overall Status: Active - Recruiting

Phase

3

Condition

Colon Cancer

Rectal Cancer

Colon Cancer; Rectal Cancer

Treatment

N/A

Clinical Study ID

NCT03925662
colon cancer
  • Ages > 18
  • All Genders

Study Summary

mebendazole treating colon cancer

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Colorectal cancer stage 4.

Exclusion

Exclusion Criteria:

  • Agranulocytosis

  • Pregnancy

  • Allergy to mebendazole.

Study Design

Total Participants: 40
Study Start date:
April 01, 2019
Estimated Completion Date:
December 31, 2028

Study Description

mebendazole as adjuvant treatment for colon cancer

Connect with a study center

  • Sherief Abd-Elsalam

    Cairo,
    Egypt

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.